Cargando…
Experimental, molecular docking investigations and bioavailability study on the inclusion complexes of finasteride and cyclodextrins
Finasteride (FIN) is a Class II candidate of the Biopharmaceutics Classification System (BCS). The lipophilic cavity of cyclodextrins (CyDs) enables it to construct a non-covalent inclusion complex with different insoluble drugs. Only β-cyclodextrin (β-CyD) and hydroxypropyl-β-CyD (HP-β-CyD) have be...
Autores principales: | Mady, Fatma M, Farghaly Aly, Usama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472428/ https://www.ncbi.nlm.nih.gov/pubmed/28652706 http://dx.doi.org/10.2147/DDDT.S135084 |
Ejemplares similares
-
Exploring the Inclusion Complex of a Drug (Umbelliferone)
with α-Cyclodextrin Optimized by Molecular Docking and
Increasing Bioavailability with Minimizing the Doses in Human Body
por: Roy, Niloy, et al.
Publicado: (2020) -
Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod
por: Garibyan, A. A., et al.
Publicado: (2023) -
Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects
por: Sarabia-Vallejo, Álvaro, et al.
Publicado: (2023) -
Preparation, Characterization, and Bioavailability of Host-Guest Inclusion Complex of Ginsenoside Re with Gamma-Cyclodextrin
por: Li, Hui, et al.
Publicado: (2021) -
Investigation of Inclusion Complex of Patchouli Alcohol with β-Cyclodextrin
por: Xu, Fangfang, et al.
Publicado: (2017)